DK146690C - Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion - Google Patents

Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion

Info

Publication number
DK146690C
DK146690C DK321180A DK321180A DK146690C DK 146690 C DK146690 C DK 146690C DK 321180 A DK321180 A DK 321180A DK 321180 A DK321180 A DK 321180A DK 146690 C DK146690 C DK 146690C
Authority
DK
Denmark
Prior art keywords
oxycarbonyldicyclohexylmethyloxypregna
9alfa
16alfa
11beta
dichlor
Prior art date
Application number
DK321180A
Other languages
English (en)
Other versions
DK321180A (da
DK146690B (da
Inventor
Roger Deraedt
Jean Georges Teutsch
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK321180A publication Critical patent/DK321180A/da
Publication of DK146690B publication Critical patent/DK146690B/da
Application granted granted Critical
Publication of DK146690C publication Critical patent/DK146690C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK321180A 1979-07-26 1980-07-25 Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion DK146690C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7919296 1979-07-26
FR7919296A FR2462443A1 (fr) 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament

Publications (3)

Publication Number Publication Date
DK321180A DK321180A (da) 1981-01-27
DK146690B DK146690B (da) 1983-12-05
DK146690C true DK146690C (da) 1984-05-21

Family

ID=9228325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK321180A DK146690C (da) 1979-07-26 1980-07-25 Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion

Country Status (20)

Country Link
US (1) US4353899A (da)
JP (1) JPS5622798A (da)
AT (1) AT371483B (da)
AU (1) AU528292B2 (da)
BE (1) BE884494A (da)
CA (1) CA1141751A (da)
CH (1) CH645389A5 (da)
DE (1) DE3028255C2 (da)
DK (1) DK146690C (da)
FI (1) FI66880C (da)
FR (1) FR2462443A1 (da)
GB (1) GB2054600B (da)
HU (1) HU180364B (da)
IE (1) IE50031B1 (da)
IT (1) IT1145302B (da)
MX (1) MX6649E (da)
NL (1) NL8004282A (da)
NO (1) NO153102C (da)
SE (1) SE447387B (da)
ZA (1) ZA803867B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
DE19932511A1 (de) * 1999-07-12 2001-01-18 Helmig Hans Gmbh Schaltvorrichtung für eine Kettengangschaltung zur Betätigung der Kettenradgruppe an der Tretkurbel eines Fahrrades

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122815C (da) * 1963-12-19
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane

Also Published As

Publication number Publication date
NO153102B (no) 1985-10-07
FR2462443B1 (da) 1982-12-31
HU180364B (en) 1983-02-28
JPS5622798A (en) 1981-03-03
IT8049248A0 (it) 1980-07-15
FI802092A (fi) 1981-01-27
IT1145302B (it) 1986-11-05
SE8004428L (sv) 1981-01-27
IE801561L (en) 1981-01-26
SE447387B (sv) 1986-11-10
IE50031B1 (en) 1986-02-05
GB2054600B (en) 1983-02-02
NL8004282A (nl) 1981-01-28
CH645389A5 (fr) 1984-09-28
NO153102C (no) 1986-01-15
US4353899A (en) 1982-10-12
GB2054600A (en) 1981-02-18
CA1141751A (fr) 1983-02-22
BE884494A (fr) 1981-01-26
AU6081180A (en) 1981-01-29
ATA391380A (de) 1982-11-15
DK321180A (da) 1981-01-27
FR2462443A1 (fr) 1981-02-13
FI66880B (fi) 1984-08-31
DE3028255A1 (de) 1981-02-19
NO802256L (no) 1981-01-27
ZA803867B (en) 1981-06-24
DK146690B (da) 1983-12-05
DE3028255C2 (de) 1985-12-19
JPS6254438B2 (da) 1987-11-14
MX6649E (es) 1985-10-01
AU528292B2 (en) 1983-04-21
AT371483B (de) 1983-06-27
FI66880C (fi) 1984-12-10

Similar Documents

Publication Publication Date Title
DK158788C (da) Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK408580A (da) Fremgangsmaade til fremstilling af 1,8-naphthydridinforbindelser
DK161147C (da) Analogifremgangsmaade til fremstilling af oe3haa-imidazo-oe5,1-daa-1,2,3,5-tetrazin-4-onderivater
DK146962C (da) Analogifremgangsmaade til fremstilling af indolizinderivater
DK155669C (da) Analogifremgangsmaade til fremstilling af pleuromutilinderivater
DK46777A (da) Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder
DK163580C (da) Analogifremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK148538C (da) Analogifremgangsmaade til fremstilling af 2,3-substituerede 4-pyroner
DK151256C (da) Analogifremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK233377A (da) Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner
DK156635C (da) Analogifremgangsmaade til fremstilling af 24,24-difluor-25-hydroxycholecalciferol
DK154434C (da) Analogifremgangsmaade til fremstilling af tripeptidderivater
DK148302C (da) Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater
DK146017C (da) Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser
DK156399C (da) Analogifremgangsmaade til fremstilling af spiro-quinolylhydantoin-derivater
DK146690C (da) Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion
DK566277A (da) Fremgangsmaade til fremstilling af 1-aminoalkyl3,4-diphenyl-1h-pyrazoler
DK301177A (da) Fremgangsmade til fremstilling af 6a,10a-cishexahydrodibenzopyranoner
DK29276A (da) Fremgangsmade til fremstilling af 8-bromothieno-triazolo-1,4-diazepiner
DK150156C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK145578C (da) Analogifremgangsmaade til fremstilling af klormetyl-17alfa-acetoxy-9alfa-fluor-11beta-hydroxy-16beta-metyl-3-oxoandrosta-1,4-dien-17beta-karboxylat
DK146129C (da) Analogifremgangsmaade til fremstilling af ergopeptidalkaloidderivater
DK149185C (da) Analogifremgangsmaade til fremstilling af trialkylsilylpropionsyreamider
DK233180A (da) Fremgangsmaade til fremstilling af 8-fluordibenzo (b,f) thiepiner
DK36679A (da) Stereospecifik fremgangsmaade til fremstilling af d,1-erythro-og d,1-threo-2-oxiranyl-1,4-benzodioxaner